event,time
spontaneous onset of labor ,-1.0
fetal distress noted on cardiotocography ,-0.5
ventouse-assisted delivery ,0.0
baby born with birth weight of 3940 grams ,0.0
immediate resuscitation with mask ventilation ,0.0
intubated at 8 minutes of age ,0.13
transferred to NICU ,0.13
commenced empirical antibiotics ,0.13
supported with SIPPV ,0.13
weaned from respiratory support ,12.0
extubated at 13.5 hours of age ,13.5
neutropenia with significant left shift ,18.0
elevated inflammatory markers ,18.0
lumbar puncture performed ,23.0
placental surface eSwab demonstrated light pure growth of an organism ,23.0
Gram-negative diplococci identified ,23.0
MALDI-TOF mass spectrometry identified Neisseria meningitidis ,23.0
molecular testing confirmed detection of meningococcus genogroup W CC11 ,23.0
blood cultures taken from newborn were negative ,0.48
heel-prick blood detected presence of N. meningitidis genogroup W DNA ,5.5
benzylpenicillin dosage decreased ,24.0
benzylpenicillin changed to cefotaxime ,24.0
completed 5-day course of β-lactam therapy ,120.0
maternal bloods showed elevated leucocyte count ,-2.5
maternal bloods showed neutrophil count of 18.1×10^9/L ,-2.5
mother remained well after birth ,0.0
baby remained well and discharged from NICU ,192.0
contact tracing identified staff members and family at risk ,192.0
chemoprophylaxis with ciprofloxacin provided ,192.0
vaccination with quadrivalent conjugate meningococcal vaccine provided ,192.0
placenta histopathology revealed acute funisitis and chorioamnionitis ,24.0
no shortness of breath ,0.0
denies chest pain ,0.0
baby required immediate resuscitation ,0.0
baby had poor respiratory effort ,0.0
baby was intubated ,0.13
baby was supported with SIPPV with minimal pressures ,0.13
baby had no additional oxygen requirement ,0.13
baby was weaned from respiratory support ,12.0
baby was extubated ,13.5
inflammatory markers were elevated ,18.0
C-reactive protein was elevated ,18.0
procalcitonin was elevated ,18.0
lumbar puncture was negative for pathogens ,23.0
lumbar puncture was negative for meningococcus ,23.0
placental surface eSwab was performed ,23.0
Gram-negative diplococci were identified ,23.0
Neisseria meningitidis was identified ,23.0
molecular testing was performed ,23.0
molecular testing confirmed detection of meningococcus ,23.0
blood cultures were taken from newborn ,0.48
blood cultures were negative ,0.48
heel-prick blood was taken ,5.5
heel-prick blood detected presence of N. meningitidis ,5.5
benzylpenicillin dosage was decreased ,24.0
benzylpenicillin was changed to cefotaxime ,24.0
β-lactam therapy was completed ,120.0
maternal bloods were taken ,-2.5
maternal bloods showed elevated leucocyte count ,-2.5
maternal bloods showed neutrophil count ,-2.5
mother remained well ,0.0
baby remained well ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
no shortness of breath ,0.0
denies chest pain ,0.0
baby required immediate resuscitation ,0.0
baby had poor respiratory effort ,0.0
baby was intubated ,0.13
baby was supported with SIPPV ,0.13
baby had no additional oxygen requirement ,0.13
baby was weaned from respiratory support ,12.0
baby was extubated ,13.5
inflammatory markers were elevated ,18.0
C-reactive protein was elevated ,18.0
procalcitonin was elevated ,18.0
lumbar puncture was negative for pathogens ,23.0
lumbar puncture was negative for meningococcus ,23.0
placental surface eSwab was performed ,23.0
Gram-negative diplococci were identified ,23.0
Neisseria meningitidis was identified ,23.0
molecular testing was performed ,23.0
molecular testing confirmed detection of meningococcus ,23.0
blood cultures were taken from newborn ,0.48
blood cultures were negative ,0.48
heel-prick blood was taken ,5.5
heel-prick blood detected presence of N. meningitidis ,5.5
benzylpenicillin dosage was decreased ,24.0
benzylpenicillin was changed to cefotaxime ,24.0
β-lactam therapy was completed ,120.0
maternal bloods were taken ,-2.5
maternal bloods showed elevated leucocyte count ,-2.5
maternal bloods showed neutrophil count ,-2.5
mother remained well ,0.0
baby remained well ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
baby had neutropenia ,18.0
baby had significant left shift ,18.0
baby had elevated CRP ,18.0
baby had elevated procalcitonin ,18.0
baby had normal cell count ,23.0
baby had negative lumbar puncture ,23.0
baby had negative blood cultures ,0.48
baby had positive heel-prick blood ,5.5
mother had elevated leucocyte count ,-2.5
mother had elevated neutrophil count ,-2.5
mother had no symptoms ,-2.5
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing was performed ,192.0
chemoprophylaxis was provided ,192.0
vaccination was provided ,192.0
placenta histopathology was performed ,24.0
placenta histopathology revealed acute funisitis ,24.0
placenta histopathology revealed chorioamnionitis ,24.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was treated with gentamicin ,0.13
baby was treated with benzylpenicillin ,0.13
baby was treated with cefotaxime ,24.0
baby completed β-lactam therapy ,120.0
staff members were at risk ,192.0
family members were at risk ,192.0
chemoprophylaxis was provided to staff members ,192.0
chemoprophylaxis was provided to family members ,192.0
vaccination was provided to staff members ,192.0
vaccination was provided to family members ,192.0
Neisseria meningitidis was detected in placental surface eSwab ,23.0
Neisseria meningitidis was detected in heel-prick blood ,5.5
Neisseria meningitidis was identified by MALDI-TOF ,23.0
Neisseria meningitidis was identified by molecular testing ,23.0
Neisseria meningitidis was serogroup W ,23.0
Neisseria meningitidis was clonal complex 11 ,23.0
baby had funisitis ,24.0
baby had chorioamnionitis ,24.0
mother had no symptoms after birth ,0.0
baby had no symptoms after discharge ,192.0
baby was discharged from NICU ,192.0
contact tracing,
